Multiple Biomarker Approach to Risk Stratification in COVID-19
Nathaniel R. Smilowitz(VA NY Harbor Healthcare System), Jeffrey S. Berger(New York University), Yuhe Xia(NYU Langone Health), Jonathan Newman(New York University), Glenn I. Fishman(New York University), Vuthy Nguy(NYU Langone Health), Yindalon Aphinyanaphongs(NYU Langone Health), Judith S. Hochman(New York University), Harmony R. Reynolds(Anna Needs Neuroblastoma Answers)
Cited by 30
Related Papers
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
|New England Journal of Medicine|2020|1.1k
ST-Segment Elevation in Patients with Covid-19 — A Case Series
|New England Journal of Medicine|2020|858
Ischemia and No Obstructive Coronary Artery Disease (INOCA)
|Circulation|2017|745
Conduction Slowing and Sudden Arrhythmic Death in Mice With Cardiac-Restricted Inactivation of Connexin43
|Circulation Research|2001|686